128 related articles for article (PubMed ID: 11504779)
1. Growth factor signaling in cell survival: implications for cancer treatment.
Talapatra S; Thompson CB
J Pharmacol Exp Ther; 2001 Sep; 298(3):873-8. PubMed ID: 11504779
[TBL] [Abstract][Full Text] [Related]
2. The role of polypeptide growth factors in human carcinomas: new targets for a novel pharmacological approach.
Favoni RE; de Cupis A
Pharmacol Rev; 2000 Jun; 52(2):179-206. PubMed ID: 10835099
[TBL] [Abstract][Full Text] [Related]
3. Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy.
Henson ES; Gibson SB
Cell Signal; 2006 Dec; 18(12):2089-97. PubMed ID: 16815674
[TBL] [Abstract][Full Text] [Related]
4. Survival factors, intracellular signal transduction, and the activation of endonucleases in apoptosis.
Eastman A
Semin Cancer Biol; 1995 Feb; 6(1):45-52. PubMed ID: 7548841
[TBL] [Abstract][Full Text] [Related]
5. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor and trail interactions in epithelial-derived cells.
Gibson SB
Vitam Horm; 2004; 67():207-27. PubMed ID: 15110179
[TBL] [Abstract][Full Text] [Related]
7. Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention.
Jazirehi AR; Bonavida B
Oncogene; 2005 Mar; 24(13):2121-43. PubMed ID: 15789036
[TBL] [Abstract][Full Text] [Related]
8. Decreases in phosphoinositide-3-kinase/Akt and extracellular signal-regulated kinase 1/2 signaling activate components of spinal motoneuron death.
Newbern J; Taylor A; Robinson M; Li L; Milligan CE
J Neurochem; 2005 Sep; 94(6):1652-65. PubMed ID: 16045454
[TBL] [Abstract][Full Text] [Related]
9. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention.
Buettner R; Mora LB; Jove R
Clin Cancer Res; 2002 Apr; 8(4):945-54. PubMed ID: 11948098
[TBL] [Abstract][Full Text] [Related]
10. Key cancer cell signal transduction pathways as therapeutic targets.
Bianco R; Melisi D; Ciardiello F; Tortora G
Eur J Cancer; 2006 Feb; 42(3):290-4. PubMed ID: 16376541
[TBL] [Abstract][Full Text] [Related]
11. EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (Review).
Navolanic PM; Steelman LS; McCubrey JA
Int J Oncol; 2003 Feb; 22(2):237-52. PubMed ID: 12527919
[TBL] [Abstract][Full Text] [Related]
12. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
13. Stat1-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand and the cell-surface death signaling pathway by interferon beta in human cancer cells.
Choi EA; Lei H; Maron DJ; Wilson JM; Barsoum J; Fraker DL; El-Deiry WS; Spitz FR
Cancer Res; 2003 Sep; 63(17):5299-307. PubMed ID: 14500361
[TBL] [Abstract][Full Text] [Related]
14. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
Yang R; Piperdi S; Gorlick R
Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
[TBL] [Abstract][Full Text] [Related]
15. Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway.
Gollob JA; Wilhelm S; Carter C; Kelley SL
Semin Oncol; 2006 Aug; 33(4):392-406. PubMed ID: 16890795
[TBL] [Abstract][Full Text] [Related]
16. The Akt/PKB pathway: molecular target for cancer drug discovery.
Cheng JQ; Lindsley CW; Cheng GZ; Yang H; Nicosia SV
Oncogene; 2005 Nov; 24(50):7482-92. PubMed ID: 16288295
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in understanding the cell death pathways activated by anticancer therapy.
Kim R
Cancer; 2005 Apr; 103(8):1551-60. PubMed ID: 15742333
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival.
Chandrasekher G; Sailaja D
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3577-88. PubMed ID: 15452065
[TBL] [Abstract][Full Text] [Related]
19. Targeting beta2-microglobulin mediated signaling as a novel therapeutic approach for human renal cell carcinoma.
Nomura T; Huang WC; Seo S; Zhau HE; Mimata H; Chung LW
J Urol; 2007 Jul; 178(1):292-300. PubMed ID: 17499801
[TBL] [Abstract][Full Text] [Related]
20. Kaempferol-induced growth inhibition and apoptosis in A549 lung cancer cells is mediated by activation of MEK-MAPK.
Nguyen TT; Tran E; Ong CK; Lee SK; Do PT; Huynh TT; Nguyen TH; Lee JJ; Tan Y; Ong CS; Huynh H
J Cell Physiol; 2003 Oct; 197(1):110-21. PubMed ID: 12942547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]